RPP Infra Projects Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 10, 2025, 11:01 pm

Competitors of RPP Infra Projects Ltd

All Competitor Stocks of RPP Infra Projects Ltd

Quarterly Result

Last Updated: August 20, 2025, 4:50 am

Below is a detailed analysis of the quarterly data for RPP Infra Projects Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 347.00 Cr.. The value appears strong and on an upward trend. It has increased from 346.00 Cr. (Mar 2025) to 347.00 Cr., marking an increase of 1.00 Cr..
• For Expenses, as of Jun 2025, the value is 328.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 333.00 Cr. (Mar 2025) to 328.00 Cr., marking a decrease of 5.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 19.00 Cr.. The value appears strong and on an upward trend. It has increased from 13.00 Cr. (Mar 2025) to 19.00 Cr., marking an increase of 6.00 Cr..
• For OPM %, as of Jun 2025, the value is 6.00%. The value appears strong and on an upward trend. It has increased from 4.00% (Mar 2025) to 6.00%, marking an increase of 2.00%.
• For Other Income, as of Jun 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
• For Interest, as of Jun 2025, the value is 5.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.00 Cr. (Mar 2025) to 5.00 Cr., marking an increase of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2025) to 15.00 Cr., marking an increase of 7.00 Cr..
• For Tax %, as of Jun 2025, the value is 27.00%. The value appears to be increasing, which may not be favorable. It has increased from -39.00% (Mar 2025) to 27.00%, marking an increase of 66.00%.
• For Net Profit, as of Jun 2025, the value is 11.00 Cr.. The value appears to be declining and may need further review. It has decreased from 12.00 Cr. (Mar 2025) to 11.00 Cr., marking a decrease of 1.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.19. The value appears to be declining and may need further review. It has decreased from 2.35 (Mar 2025) to 2.19, marking a decrease of 0.16.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 23, 2025, 2:13 pm

Growth

Last Updated: September 5, 2025, 12:50 pm

Balance Sheet

Last Updated: October 10, 2025, 2:48 pm

Below is a detailed analysis of the balance sheet data for RPP Infra Projects Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 50.00 Cr.. The value appears strong and on an upward trend. It has increased from 38.00 Cr. (Mar 2024) to 50.00 Cr., marking an increase of 12.00 Cr..
• For Reserves, as of Mar 2025, the value is 480.00 Cr.. The value appears strong and on an upward trend. It has increased from 388.00 Cr. (Mar 2024) to 480.00 Cr., marking an increase of 92.00 Cr..
• For Borrowings, as of Mar 2025, the value is 44.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 41.00 Cr. (Mar 2024) to 44.00 Cr., marking an increase of 3.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 380.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 366.00 Cr. (Mar 2024) to 380.00 Cr., marking an increase of 14.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 953.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 833.00 Cr. (Mar 2024) to 953.00 Cr., marking an increase of 120.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 105.00 Cr.. The value appears strong and on an upward trend. It has increased from 65.00 Cr. (Mar 2024) to 105.00 Cr., marking an increase of 40.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 2.00 Cr..
• For Investments, as of Mar 2025, the value is 7.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 7.00 Cr., marking an increase of 7.00 Cr..
• For Other Assets, as of Mar 2025, the value is 841.00 Cr.. The value appears strong and on an upward trend. It has increased from 766.00 Cr. (Mar 2024) to 841.00 Cr., marking an increase of 75.00 Cr..
• For Total Assets, as of Mar 2025, the value is 953.00 Cr.. The value appears strong and on an upward trend. It has increased from 833.00 Cr. (Mar 2024) to 953.00 Cr., marking an increase of 120.00 Cr..

Notably, the Reserves (480.00 Cr.) exceed the Borrowings (44.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for RPP Infra Projects Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 13.17. This value is within the healthy range. It has decreased from 15.11 (Mar 24) to 13.17, marking a decrease of 1.94.
• For Diluted EPS (Rs.), as of Mar 25, the value is 13.17. This value is within the healthy range. It has decreased from 14.05 (Mar 24) to 13.17, marking a decrease of 0.88.
• For Cash EPS (Rs.), as of Mar 25, the value is 15.10. This value is within the healthy range. It has decreased from 17.89 (Mar 24) to 15.10, marking a decrease of 2.79.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 106.85. It has decreased from 112.02 (Mar 24) to 106.85, marking a decrease of 5.17.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 106.85. It has decreased from 112.02 (Mar 24) to 106.85, marking a decrease of 5.17.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 290.27. It has decreased from 356.72 (Mar 24) to 290.27, marking a decrease of 66.45.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 21.56. This value is within the healthy range. It has decreased from 28.19 (Mar 24) to 21.56, marking a decrease of 6.63.
• For PBIT / Share (Rs.), as of Mar 25, the value is 19.62. This value is within the healthy range. It has decreased from 25.38 (Mar 24) to 19.62, marking a decrease of 5.76.
• For PBT / Share (Rs.), as of Mar 25, the value is 17.30. This value is within the healthy range. It has decreased from 22.21 (Mar 24) to 17.30, marking a decrease of 4.91.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 13.16. This value is within the healthy range. It has decreased from 15.08 (Mar 24) to 13.16, marking a decrease of 1.92.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 13.16. This value is within the healthy range. It has decreased from 15.08 (Mar 24) to 13.16, marking a decrease of 1.92.
• For PBDIT Margin (%), as of Mar 25, the value is 7.42. This value is below the healthy minimum of 10. It has decreased from 7.90 (Mar 24) to 7.42, marking a decrease of 0.48.
• For PBIT Margin (%), as of Mar 25, the value is 6.76. This value is below the healthy minimum of 10. It has decreased from 7.11 (Mar 24) to 6.76, marking a decrease of 0.35.
• For PBT Margin (%), as of Mar 25, the value is 5.95. This value is below the healthy minimum of 10. It has decreased from 6.22 (Mar 24) to 5.95, marking a decrease of 0.27.
• For Net Profit Margin (%), as of Mar 25, the value is 4.53. This value is below the healthy minimum of 5. It has increased from 4.22 (Mar 24) to 4.53, marking an increase of 0.31.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.53. This value is below the healthy minimum of 8. It has increased from 4.22 (Mar 24) to 4.53, marking an increase of 0.31.
• For Return on Networth / Equity (%), as of Mar 25, the value is 12.32. This value is below the healthy minimum of 15. It has decreased from 13.45 (Mar 24) to 12.32, marking a decrease of 1.13.
• For Return on Capital Employeed (%), as of Mar 25, the value is 17.89. This value is within the healthy range. It has decreased from 21.44 (Mar 24) to 17.89, marking a decrease of 3.55.
• For Return On Assets (%), as of Mar 25, the value is 6.84. This value is within the healthy range. It has increased from 6.79 (Mar 24) to 6.84, marking an increase of 0.05.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.04 (Mar 24) to 0.01, marking a decrease of 0.03.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.06. This value is within the healthy range. It has decreased from 0.09 (Mar 24) to 0.06, marking a decrease of 0.03.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.60. It has decreased from 1.67 (Mar 24) to 1.60, marking a decrease of 0.07.
• For Current Ratio (X), as of Mar 25, the value is 1.67. This value is within the healthy range. It has decreased from 1.75 (Mar 24) to 1.67, marking a decrease of 0.08.
• For Quick Ratio (X), as of Mar 25, the value is 1.59. This value is within the healthy range. It has decreased from 1.70 (Mar 24) to 1.59, marking a decrease of 0.11.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 10.78. This value exceeds the healthy maximum of 8. It has decreased from 16.43 (Mar 24) to 10.78, marking a decrease of 5.65.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 9.27. This value is within the healthy range. It has increased from 8.90 (Mar 24) to 9.27, marking an increase of 0.37.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 6.66. This value is within the healthy range. It has increased from 5.76 (Mar 24) to 6.66, marking an increase of 0.90.
• For Enterprise Value (Cr.), as of Mar 25, the value is 536.57. It has increased from 412.78 (Mar 24) to 536.57, marking an increase of 123.79.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.48. This value is below the healthy minimum of 1. It has increased from 0.30 (Mar 24) to 0.48, marking an increase of 0.18.
• For EV / EBITDA (X), as of Mar 25, the value is 6.50. This value is within the healthy range. It has increased from 3.86 (Mar 24) to 6.50, marking an increase of 2.64.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.47. This value is below the healthy minimum of 1. It has increased from 0.30 (Mar 24) to 0.47, marking an increase of 0.17.
• For Price / BV (X), as of Mar 25, the value is 1.29. This value is within the healthy range. It has increased from 0.96 (Mar 24) to 1.29, marking an increase of 0.33.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.47. This value is below the healthy minimum of 1. It has increased from 0.30 (Mar 24) to 0.47, marking an increase of 0.17.
• For EarningsYield, as of Mar 25, the value is 0.09. This value is below the healthy minimum of 5. It has decreased from 0.13 (Mar 24) to 0.09, marking a decrease of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness